ArticleBriefings in bioinformatics2026
BCRInsight: an antibody language model to decode biological signals from BCR sequences.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- DNAreader: accurate prediction of DNA-binding residues in structured and disordered proteins using transformers and contrastive learning.Nucleic acids research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The B-cell receptor (BCR) repertoire encodes not only antigen-binding specificity but also intrinsic signatures reflecting B-cell functional states and differentiation trajectories. Deciphering the intricate sequence semantics embedded within these repertoires is pivotal for elucidating immune dynamics and expediting antibody discovery. Although single-cell sequencing provides high-resolution insights, its scalability and cost remain major obstacles, leaving population-level repertoire data underexploited. Furthermore, conventional bioinformatics approaches struggle to model the high-order, non-linear semantic dependencies inherent in antibody sequences. To address these challenges, we present BCRInsight, an antibody-specific pretrained language model that integrates a Transformer architecture with phenotype-aware contrastive learning. Pretrained on 80 million human BCR sequences, BCRInsight learns biologically meaningful contextual representations that encode subtle signatures of B-cell activation, maturation, and clonal evolution. Extensive benchmarking demonstrates that BCRInsight achieves state-of-the-art performance across multiple downstream tasks, particularly in paratope prediction. Further evaluation on diverse single-cell immune cohorts, including healthy, neoplastic, and viral infection states, reveals cross-scenario robustness and superior generalization relative to existing methods. Notably, attention-based analyses show that high-attention regions correspond closely to physical antigen-contact residues, highlighting emergent structural interpretability derived solely from self-supervised learning. Collectively, BCRInsight establishes a new paradigm for decoding the "language" of antibodies, offering a scalable and interpretable framework for computational immunology and rational antibody engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.